Mar 22, 2022

Scientists discover how molecule becomes anticancer weapon

Posted by in categories: biotech/medical, chemistry, neuroscience

Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule.

The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat glioblastoma, a . Scientists now for the first time understand the -driven process that activates the molecule.

Researchers at UC San Diego’s Scripps Institution of Oceanography found that an enzyme called SalC assembles what the team calls the salinosporamide anti-cancer “warhead.” Scripps graduate student Katherine Bauman is the lead author of a paper that explains the assembly process in the March 21 issue of Nature Chemical Biology.

Comments are closed.